B.More Inc.: Ground-breaking Trial on the Benefits of Psilocybin Therapy for Alcohol Dependence Published by B.More Principal Investigator, Michael Bogenschutz
Clinical trial results published in JAMA Psychiatry show reduction in alcohol consumption by an average of 83% among heavy drinkers following two doses of psilocybin combined with psychotherapy GREENWICH